Management of male breast cancer

  • Nikolay V. Dimitro v | dimitrov@msu.edu Michigan State University, Department of Medicine, Division of Hematology/Oncology, East Lansing, Michigan, United States.
  • Sunil Nagpal Michigan State University, Department of Medicine, Division of Hematology/Oncology, East Lansing, Michigan, .
  • Shalini Chitneni Michigan State University, Department of Medicine, Division of Hematology/Oncology, East Lansing, Michigan, United States.

Abstract

The management of male breast cancer is still under discussion due to lack of information from prospective, randomized clinical trials and low incidence of this disease. Current management is based largely on extrapolation from data related to treatment of female breast cancer. Over the last two decades, several review articles have discussed mainly retrospective and anecdotal data related to hormonal and chemotherapy treatment modalities. In this review, we present the most recent information and future considerations related to the management of male breast cancer. In addition to the conventional treatment options we will discuss the possible role of targeted therapy. Establishing a national or global registry for male breast cancer will provide more precise information about the natural history of the disease and will facilitate the design and execution of prospective, randomized multicenter clinical trials.

Downloads

Download data is not yet available.
Published
2011-12-14
Section
Reviews
Keywords:
Male breast cancer - Management
Statistics
Abstract views: 1034

FULL TEXT: 237
Share it
How to Cite
Dimitro v, N. V., Nagpal, S., & Chitneni, S. (2011). Management of male breast cancer. Oncology Reviews, 2(1), 44-52. Retrieved from https://www.oncologyreviews.org/index.php/or/article/view/oncol.2008.44